The alpha-glucosidase inhibitor acarbose reduces the net electronegative charge of low-density lipoprotein in patients with newly diagnosed type 2 diabetes.
Hasegawa G, Kajiyama S, Tanaka T, Imai S, Kozai H, Fujinami A, Ohta M, Obayashi H, Park H, Nakano K, Tanaka M, Shiraishi E, Fukui M, Yoshikawa T, Nakamura N.
Hasegawa G, et al. Among authors: tanaka m, tanaka t.
Clin Chim Acta. 2008 Apr;390(1-2):110-4. doi: 10.1016/j.cca.2008.01.005. Epub 2008 Jan 12.
Clin Chim Acta. 2008.
PMID: 18230353
Clinical Trial.